|
|
Volumn 190, Issue 4, 2014, Pages 468-
|
|
Improvement of sinus disease in cystic fibrosis with ivacaftor therapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;
IVACAFTOR;
MONTELUKAST;
ACETIC ACID DERIVATIVE;
AMINOPHENOL DERIVATIVE;
ANDROSTANE DERIVATIVE;
ANTIALLERGIC AGENT;
FLUTICASONE;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
N-(2,4-DI-TERT-BUTYL-5-HYDROXYPHENYL)-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXAMIDE;
QUINOLINE DERIVATIVE;
QUINOLONE DERIVATIVE;
ADULT;
ARTICLE;
BRONCHIECTASIS;
CASE REPORT;
COMPUTER ASSISTED TOMOGRAPHY;
CYSTIC FIBROSIS;
FEMALE;
HUMAN;
NOSE OBSTRUCTION;
PARANASAL SINUS DISEASE;
PRIORITY JOURNAL;
PSEUDOMONAS AERUGINOSA;
PERENNIAL RHINITIS;
TREATMENT OUTCOME;
YOUNG ADULT;
ACETATES;
ADULT;
AMINOPHENOLS;
ANDROSTADIENES;
ANTI-ALLERGIC AGENTS;
CYSTIC FIBROSIS;
FEMALE;
HUMANS;
LEUKOTRIENE ANTAGONISTS;
PARANASAL SINUS DISEASES;
QUINOLINES;
QUINOLONES;
RHINITIS, ALLERGIC, PERENNIAL;
TREATMENT OUTCOME;
YOUNG ADULT;
|
|
EID: 84907843577
PISSN: 1073449X
EISSN: 15354970
Source Type: Journal
DOI: 10.1164/rccm.201403-0595IM Document Type: Article |
|
Times cited : (26)
|
|
References (0)
|